Nephrology & Hypertension Specialists

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Alebund Pharmaceuticals1 trial
• R1 Therapeutics1 trial

Running trials

• Recruiting

  A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

  NCT06712654· Phase 2· R1 Therapeutics· Source

• Recruiting

  A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

  NCT06933472· Phase 3· Alebund Pharmaceuticals· Source

  Contact: Frank Newby, M.D.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting